Loading...
| A00007 | Pages: NA | Feb 2022 | 31653 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the World Top 10 Noninvasive Diagnostics Market
Request Now !Non-invasive diagnostics is a process of identifying the disease conditions with minimal incision to the body during diagnosis. Non-invasive diagnostic market is segment of diagnostic market, which was valued at approximately $46 billion in 2011. The non-invasive diagnostic market is mainly driven by increasing rate of prevalence of chronic disease such as CVD, Neurological disease. More than 64.4 million people are suffering from various type of CVD in the U.S, out of which nearly 2,600 people die in a day. The growth of non-invasive diagnostics market has been hindered by availability of non-invasive diagnostic services. Developing countries are not getting non-invasive diagnostic services due to lack of awareness.
Companies involved in manufacturing of non-invasive diagnostic tools are facing challenges because of increasing complexity of diseases. Diagnostic devices used in identification of neurological diseases require some amount of incision that make diagnostic process complex. In order to overcome these problem companies are conducting research on improving diagnostic process in neurological diseases. This report provides strategic intelligence of key developmental strategies adopted by key market players engaged in this business. The report gives patent analysis of the granted patent according to geographies.
The key companies included in the report are: Arthrocare Corp , Charles Russell Bard Inc , Boston Scientific Corporation , Depuy Spine Inc , Hansen Medical , Intuitive Surgical Inc , Karl Storz Endoscope Berlin Gmbh , Pentax Medical Company , Stryker Corporation , Teleflex Medical
Key Benefits
MARKET SEGMENTS
GLOBAL MARKET, BY TECHNOLOGIES
GLOBAL MARKET, BY APPLICATIONS
GLOBAL MARKET, BY GEOGRAPHIES
KEY AUDIENCES
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH THERAPEUTIC CLASSOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 TOP 10 NONINVASIVE DIAGNOSTICS MARKET, BY TECHNOLOGIES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. X-RAY
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. ULTRASOUND
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. MAGNETIC RESONANCE IMAGING (MRI)
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. COMPUTED TOMOGRAPHY
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. BONE DENSITOMETRY
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. NUCLEAR IMAGING
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. MAMMOGRAPHY
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. LIQUID BIOPSY
4.9.1. Key market trends, growth factors and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. ENDOSCOPY
4.10.1. Key market trends, growth factors and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
4.11. ELECTROCARDIOGRAPH (ECG)
4.11.1. Key market trends, growth factors and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country
CHAPTER 5 TOP 10 NONINVASIVE DIAGNOSTICS MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends, growth factors and opportunities
5.2.2. North America top 10 noninvasive diagnostics market, by country
5.2.2.1. U.S. top 10 noninvasive diagnostics market size and forecast, by technologies
5.2.2.2. Canada 10 noninvasive diagnostics market size and forecast, by technologies
5.2.2.3. Mexico 10 noninvasive diagnostics market size and forecast, by technologies
5.2.3. North America top 10 noninvasive diagnostics market, by technologies
5.3. EUROPE
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Europe top 10 noninvasive diagnostics market, by country
5.3.2.1. Germany top 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.2. France 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.3. UK 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.4. Italy top 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.5. Spain 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.6. Rest of Europe 10 noninvasive diagnostics market size and forecast, by technologies
5.3.3. Europe top 10 noninvasive diagnostics market, by technologies
5.4. ASIA-PACIFIC
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Asia-Pacific top 10 noninvasive diagnostics market, by country
5.4.2.1. Japan top 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.2. China 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.3. India 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.4. Australia top 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.5. South Korea 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.6. Rest of Asia-Pacific 10 noninvasive diagnostics market size and forecast, by technologies
5.4.3. Asia-Pacific top 10 noninvasive diagnostics market, by technologies
5.5. LAMEA
5.5.1. Key market trends, growth factors and opportunities
5.5.2. LAMEA top 10 noninvasive diagnostics market, by country
5.5.2.1. Brazil top 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.2. Saudi Arabia 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.3. South Africa 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.4. Rest of LAMEA 10 noninvasive diagnostics market size and forecast, by technologies
5.5.3. LAMEA top 10 noninvasive diagnostics market, by technologies
CHAPTER 6 COMPANY PROFILES
6.1. GE HEALTHCARE
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. PHILIPS HEALTHCARE
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. HITACHI MEDICAL CORPORATION
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. HOLOGIC, INC.
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. SIEMENS HEALTHCARE
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. SHIMADZU CORPORATION
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. TOSHIBA MEDICAL SYSTEMS CORPORATION
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. ESAOTE S.P.A
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. FUJIFILM CORPORATION
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments
6.11. F. HOFFMANN-LA ROCHE AG
6.11.1. Operating business segments
6.11.2. Business pertherapeutic classance
6.11.3. Key strategic moves and developments
6.12. BIO-RAD LABORATORIES, INC.
6.12.1. Operating business segments
6.12.2. Business pertherapeutic classance
6.12.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
